Versant Capital Management Inc lifted its position in shares of Henry Schein, Inc. (NASDAQ:HSIC – Free Report) by 274.6% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 457 shares of the company’s stock after acquiring an additional 335 shares during the quarter. Versant Capital Management Inc’s holdings in Henry Schein were worth $32,000 at the end of the most recent quarter.
Other large investors have also recently added to or reduced their stakes in the company. Principal Financial Group Inc. increased its position in Henry Schein by 2.1% during the 3rd quarter. Principal Financial Group Inc. now owns 145,835 shares of the company’s stock worth $10,631,000 after purchasing an additional 3,037 shares during the period. Franklin Resources Inc. grew its holdings in Henry Schein by 14.0% during the third quarter. Franklin Resources Inc. now owns 37,637 shares of the company’s stock worth $2,673,000 after acquiring an additional 4,621 shares during the period. Tidal Investments LLC raised its position in Henry Schein by 54.9% in the third quarter. Tidal Investments LLC now owns 13,942 shares of the company’s stock worth $1,016,000 after acquiring an additional 4,939 shares in the last quarter. Wilmington Savings Fund Society FSB acquired a new stake in Henry Schein in the third quarter valued at $109,000. Finally, Virtu Financial LLC purchased a new stake in shares of Henry Schein during the 3rd quarter worth $239,000. 96.62% of the stock is owned by hedge funds and other institutional investors.
Henry Schein Price Performance
NASDAQ:HSIC opened at $71.67 on Wednesday. Henry Schein, Inc. has a 12-month low of $63.67 and a 12-month high of $82.63. The firm has a market cap of $8.94 billion, a price-to-earnings ratio of 29.49, a price-to-earnings-growth ratio of 2.30 and a beta of 0.89. The company’s 50-day moving average is $72.13 and its two-hundred day moving average is $70.37. The company has a current ratio of 1.42, a quick ratio of 0.82 and a debt-to-equity ratio of 0.46.
Analyst Ratings Changes
A number of equities analysts have recently issued reports on HSIC shares. StockNews.com upgraded shares of Henry Schein from a “sell” rating to a “hold” rating in a report on Thursday, November 7th. Evercore ISI increased their target price on shares of Henry Schein from $70.00 to $74.00 and gave the company an “in-line” rating in a report on Tuesday, October 8th. Barrington Research reissued an “outperform” rating and set a $82.00 price target on shares of Henry Schein in a research note on Wednesday, November 6th. Mizuho initiated coverage on Henry Schein in a research note on Wednesday, December 4th. They issued a “neutral” rating and a $75.00 price objective for the company. Finally, Bank of America raised Henry Schein from an “underperform” rating to a “buy” rating and lifted their price objective for the stock from $69.00 to $84.00 in a report on Monday. Seven analysts have rated the stock with a hold rating, five have given a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average target price of $79.40.
Get Our Latest Report on Henry Schein
Insider Transactions at Henry Schein
In related news, COO Michael S. Ettinger sold 12,240 shares of the firm’s stock in a transaction that occurred on Monday, November 18th. The shares were sold at an average price of $75.00, for a total value of $918,000.00. Following the sale, the chief operating officer now directly owns 87,706 shares of the company’s stock, valued at approximately $6,577,950. This trade represents a 12.25 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Insiders own 1.14% of the company’s stock.
Henry Schein Profile
Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.
Read More
- Five stocks we like better than Henry Schein
- How to Calculate Stock Profit
- Disney: Forging a 3-Headed Sports Streaming Giant With Fubo Deal
- Low PE Growth Stocks: Unlocking Investment Opportunities
- How Buffett’s Best and Worst Stock Bets Have Fared 5 Years Later
- How to buy stock: A step-by-step guide for beginners
- Bill Ackman’s Bold Case for Fannie Mae and Freddie Mac
Want to see what other hedge funds are holding HSIC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Henry Schein, Inc. (NASDAQ:HSIC – Free Report).
Receive News & Ratings for Henry Schein Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein and related companies with MarketBeat.com's FREE daily email newsletter.